Povetacicept for Treatment of IgA Nephropathy: RAINIER Phase 3 Interim Efficacy and Safety Analysis (IA) (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #SA-OR076; Pres time: Oct 24, 2026; 05:06 PM - 05:18 PM; Location: Four Seasons Ballroom 2; No abstract available
Clinical • Late-breaking abstract • P3 data • P3 data: top line • Glomerulonephritis • IgA Nephropathy • Renal Disease
|
|
Richard A. Lafayette; Hong Zhang; Seung Hyeok Han; Yusuke Suzuki; James A. Tumlin; Bobby Chacko; Irene L. Noronha; Arvind Madan; Raphael Duivenvoorden; Jamil R. Azzi; Carla M. Nester; Cassie Dong; Neil Ahluwalia; Jiahua Li; Carmen Bozic; Ogo I. Egbuna; Muh Geot Wong; Jonathan Barratt
|